Stockreport

Innate Pharma Highlights FDA-Approved Lumoxiti® at ASH 2019

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF MARSEILLE, France, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) shared new, [Read more]